Recombinant Human KAT8 / MYST1 / MOF protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human KAT8 / MYST1 / MOF protein is a Human Full Length protein, in the 2 to 467 aa range, expressed in Baculovirus infected Sf9 cells, with >80%, suitable for SDS-PAGE, WB.
View Alternative Names
MOF, MYST1, PP7073, KAT8, Histone acetyltransferase KAT8, Lysine acetyltransferase 8, Males-absent on the first protein homolog, Protein acetyltransferase KAT8, Protein propionyltransferase KAT8, MYST-1, hMOF
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human KAT8 / MYST1 / MOF protein (AB125660)
SDS-PAGE analysis of ab125660.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KAT8 plays an essential role in gene transcription regulation by forming part of a complex known as the MSL (Male-Specific Lethal) complex. This complex ensures dosage compensation in Drosophila by adjusting gene expression levels. KAT8 is vital for the maintenance of chromatin structure influencing gene activation and silencing across various biological systems. It interacts with several co-factors during transcription regulation further highlighting its functional significance in the epigenetic landscape.
Pathways
KAT8 engages in processes linked to chromatin modification and gene expression. Specifically it plays a significant role in the pathways of chromatin organization and transcriptional regulation by RNA polymerase II. The protein ENL participates in related pathways and interacts with KAT8 during transcription elongation. These interactions highlight KAT8's role in epigenetic regulation affecting multiple genes' transcription states.
Specifications
Form
Liquid
Additional notes
Purity was determined to be >80% by densitometry. Affinity purified.
General info
Function
Histone acetyltransferase that catalyzes histone H4 acetylation at 'Lys-5'- and 'Lys-8' (H4K5ac and H4K8ac) or 'Lys-16' (H4K16ac), depending on the context (PubMed : 12397079, PubMed : 16227571, PubMed : 16543150, PubMed : 20018852, PubMed : 21217699, PubMed : 22020126, PubMed : 22547026, PubMed : 31794431, PubMed : 33837287). Catalytic component of the MSL histone acetyltransferase complex, a multiprotein complex that mediates the majority of histone H4 acetylation at 'Lys-16' (H4K16ac), an epigenetic mark that prevents chromatin compaction (PubMed : 12397079, PubMed : 16227571, PubMed : 16543150, PubMed : 21217699, PubMed : 22020126, PubMed : 22547026, PubMed : 33657400, PubMed : 33837287). H4K16ac constitutes the only acetylation mark intergenerationally transmitted and regulates key biological processes, such as oogenesis, embryonic stem cell pluripotency, hematopoiesis or glucose metabolism (By similarity). The MSL complex is required for chromosome stability and genome integrity by maintaining homeostatic levels of H4K16ac (PubMed : 33837287). The MSL complex is also involved in gene dosage by promoting up-regulation of genes expressed by the X chromosome (By similarity). X up-regulation is required to compensate for autosomal biallelic expression (By similarity). The MSL complex also participates in gene dosage compensation by promoting expression of Tsix non-coding RNA (By similarity). As part of the NSL histone acetyltransferase complex, catalyzes histone H4 acetylation at 'Lys-5'- and 'Lys-8' (H4K5ac and H4K8ac) at transcription start sites and promotes transcription initiation (PubMed : 20018852, PubMed : 22547026, PubMed : 33657400). The NSL complex also acts as a regulator of gene expression in mitochondria : KAT8 associates with mitochondrial DNA and controls expression of respiratory genes in an acetyltransferase-dependent mechanism (PubMed : 27768893). Also functions as an acetyltransferase for non-histone targets, such as ALKBH5, COX17, IRF3, KDM1A/LSD1, LMNA, PAX7 or TP53/p53 (PubMed : 17189187, PubMed : 19854137, PubMed : 37369679). Acts as an inhibitor of antiviral immunity by acetylating IRF3, preventing IRF3 recruitment to promoters (By similarity). Acts as a regulator of asymmetric division in muscle stem cells by mediating acetylation of PAX7 (By similarity). As part of the NSL complex, acetylates TP53/p53 at 'Lys-120' (PubMed : 17189187, PubMed : 19854137). Acts as a regulator of epithelial-to-mesenchymal transition as part of the NSL complex by mediating acetylation of KDM1A/LSD1 (PubMed : 27292636). The NSL complex is required for nuclear architecture maintenance by mediating acetylation of LMNA (By similarity). Promotes mitochondrial integrity by catalyzing acetylation of COX17 (By similarity). In addition to protein acetyltransferase activity, able to mediate protein propionylation (PubMed : 29321206).
Sequence similarities
Belongs to the MYST (SAS/MOZ) family.
Post-translational modifications
Acetylation at Lys-274 facilitates cognate substrate Lys-binding and acetylation (PubMed:22020126, PubMed:27382063). Although considered as an autoacetylation event, acetylation at Lys-274 probably takes place via a non-enzymatic process following acetyl-CoA-binding, which primes KAT8 for cognate protein-lysine acetylation (PubMed:27382063). Deacetylated by SIRT1 (PubMed:22918831).
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com